Acute motor axonal polyneuropathy in one parkinsonian patient receiving moderate dosage of oral levodopa

Neurol Sci. 2021 Jun;42(6):2555-2557. doi: 10.1007/s10072-020-04989-z. Epub 2021 Jan 11.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiparkinson Agents / adverse effects
  • Humans
  • Levodopa / adverse effects
  • Parkinson Disease*
  • Polyneuropathies* / chemically induced
  • Polyneuropathies* / drug therapy

Substances

  • Antiparkinson Agents
  • Levodopa